½ÃÀ庸°í¼­
»óǰÄÚµå
1488255

24½Ã°£ Ç÷¾ÐÃøÁ¤ ±â±â(ABPM) ½ÃÀå : ±â±â À¯Çüº°, µ¿ÀÛº°, ±¸¼ºº°, ¼¼°è ¿¹Ãø(2024-2032³â)

Ambulatory Blood Pressure Monitoring Devices Market - By Device Type (Products [Digital, Aneroid, Mercury], Accessories), Operation (Automatic, Semi-automatic, Manual), Configuration (Portable, Desk Mounted, Floor, Wall) - Global Forecast, 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

24½Ã°£ Ç÷¾ÐÃøÁ¤ ±â±â(ABPM) ½ÃÀå ±Ô¸ð´Â Àü ¼¼°è °íÇ÷¾Ð ¹× °ü·Ã ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ÈûÀÔ¾î 2024-2032³â »çÀÌ ¿¬Æò±Õ 8.5%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°íÇ÷¾ÐÀº Àü ¼¼°è ¼ºÀÎ 3¸í Áß 1¸íÀÌ ¾Î°í ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖÀ¸¸ç, 24½Ã°£ Ç÷¾ÐÃøÁ¤ ±â±â(ABPM)´Â Ç÷¾ÐÀ» Áö¼ÓÀûÀ¸·Î ºñħ½ÀÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ¿© ÀÇ·áÁø¿¡°Ô ȯÀÚÀÇ Ç÷¾Ð º¯µ¿¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ¿¹¹æÀû °Ç°­°ü¸®¿Í Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ Á߿伺ÀÌ °­Á¶µÇ¸é¼­ ÀÌ Á¦Ç°ÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

24½Ã°£ Ç÷¾ÐÃøÁ¤ ±â±â(ABPM)ÀÇ ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ Á¤È®¼º°ú ÆíÀǼºÀÌ °­È­µÈ ¼ÒÇü ¿þ¾î·¯ºí ±â±â°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â »ç¿ëÀ» ÃËÁøÇϱâ À§ÇÑ Á¤ºÎ ¹× ÀÇ·á±â°üÀÇ ÀÌ´Ï¼ÅÆ¼ºê°¡ °áÇÕµÇ¾î ½ÃÀå ¼ºÀåÀ» °áÁ¤ÇÕ´Ï´Ù.

24½Ã°£ Ç÷¾ÐÃøÁ¤ ±â±â(ABPM) »ê¾÷Àº ±â±â À¯Çü, ÀÛµ¿, ±¸¼º ¹× Áö¿ª¿¡ µû¶ó ºÐ·ùµË´Ï´Ù.

¾×¼¼¼­¸® ±â±â À¯Çü ºÎ¹®ÀÇ ½ÃÀå ±Ô¸ð´Â ¿¹Ãø ±â°£ µ¿¾È 8.2%ÀÇ CAGR·Î ÁÖ¸ñÇÒ ¸¸ÇÑ ¼öÀÍÀ» âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °íÇ÷¾ÐÀÇ Àå±âÀûÀÎ ¸ð´ÏÅ͸µÀ» À§ÇÑ 24½Ã°£ Ç÷¾ÐÃøÁ¤ ±â±â(ABPM)ÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ÃøÁ¤À» º¸ÀåÇϱâ À§ÇÑ È£È¯ °¡´ÉÇÑ ¾×¼¼¼­¸®ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ä¿ÇÁ, ¾î´ðÅÍ, ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼Ç°ú °°Àº ¾×¼¼¼­¸®´Â Á¦Ç°ÀÇ ±â´É¼º°ú »ç¿ë ÆíÀǼºÀ» Çâ»ó½ÃÄÑ Á¦Ç° ¼ö¿ä¸¦ ÃËÁøÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

¼öµ¿ ÀÛµ¿ ¹æ½ÄÀÇ 24½Ã°£ Ç÷¾ÐÃøÁ¤ ±â±â(ABPM) ½ÃÀåÀº 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 7.9%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÚµ¿ ¸ð´ÏÅ͸µ ±â±âÀÇ ÃâÇö¿¡µµ ºÒ±¸ÇÏ°í ¼öµ¿ Ç÷¾Ð ¸ð´ÏÅÍ´Â Ç÷¾Ð ÃøÁ¤ÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀ¸·Î ÀÎÇØ ÀÇ·á Á¾»çÀÚµéÀÌ °è¼Ó ¼±È£Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼öµ¿ Ç÷¾Ð°è´Â ÀÚµ¿È­µÈ ´ëüǰº¸´Ù ºñ¿ë È¿À²ÀûÀ̱⠶§¹®¿¡ ƯÈ÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼­ ´õ ¸¹Àº ÀÇ·á ½Ã¼³°ú ȯÀÚµéÀÌ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ 24½Ã°£ Ç÷¾ÐÃøÁ¤ ±â±â(ABPM) ½ÃÀåÀº °íÇ÷¾Ð ¹× ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ 202-2032³â ¿¬Æò±Õ 9.4%ÀÇ CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÄÄÆÑÆ®ÇÏ°í »ç¿ëÇϱ⠽¬¿î ABPMÀÇ °³¹ß°ú °°Àº ±Þ¼ÓÇÑ ±â¼ú ¹ßÀüÀº ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ¿¡¼­ ABPMÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÇ·áºñ ÁöÃâ Áõ°¡, Á¤±âÀûÀÎ Ç÷¾Ð ¸ð´ÏÅ͸µÀÇ Á߿伺¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¿¹¹æÀû ÀÇ·á Á¶Ä¡¸¦ Àå·ÁÇϱâ À§ÇÑ Á¤ºÎÀÇ Àû±ØÀûÀÎ ³ë·Âµµ ÀÌ Áö¿ªÀÇ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °íÇ÷¾Ð°ú ½ÉÇ÷°üÁúȯ À¯º´·ü Áõ°¡
      • ¿¹¹æ ÇコÄɾ ´ëÇÑ ÁÖ¸ñ »ó½Â
      • ±â¼úÀÇ Áøº¸
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©¿Í °úÁ¦
      • Ç÷¾Ð ¸ð´ÏÅ͸µ ±â±â °ü·Ã °íºñ¿ë
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼úÀû Àü¸Á
  • °¡°Ý ºÐ¼®, 2023³â
  • Porters ºÐ¼®
  • PESTEL ºÐ¼®
  • »óȯ ½Ã³ª¸®¿À
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • °ÝÂ÷ ºÐ¼®

Á¦4Àå °æÀï »óȲ

  • ¼Ò°³
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : ±â±â À¯Çüº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • Á¦Ç°
    • µðÁöÅÐ BP ¸ð´ÏÅÍ
      • »ó¿Ï¿ë ¸ð´ÏÅÍ
      • ¼Õ¸ñ¿ë ¸ð´ÏÅÍ
      • ¼Õ°¡¶ô¿ë ¸ð´ÏÅÍ
    • ¾Æ³×·ÎÀ̵å BP ¸ð´ÏÅÍ
    • ¼öÀº BP ¸ð´ÏÅÍ
  • ºÎ¼Óǰ

Á¦6Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : µ¿ÀÛº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ÀÚµ¿
  • ¹ÝÀÚµ¿
  • ¼öµ¿

Á¦7Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : ±¸¼ºº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ÈÞ´ë¿ë
  • Ã¥»ó ¼³Ä¡
  • ¹Ù´Ú ¼³Ä¡
  • º® ¼³Ä¡

Á¦8Àå ½ÃÀå ÃßÁ¤°ú ¿¹Ãø : Áö¿ªº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • A&D Company, Limited
  • American Diagnostic Corporation
  • Beurer GmbH
  • Contec
  • Dr. Morepen
  • ForaCare, Inc.
  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • iHealth Labs Inc
  • Koninklijke Philips N.V.
  • Microlife Corporation
  • OMRON Corporation
  • Rossmax International Ltd.
ksm 24.06.10

Ambulatory blood pressure monitoring devices market size is anticipated to grow at 8.5% CAGR between 2024 and 2032, driven by the rising prevalence of hypertension and related cardiovascular diseases worldwide. As per who, hypertension affects 1 in 3 adults worldwide. Ambulatory blood pressure monitoring (ABPM) devices offer continuous and non-invasive monitoring of blood pressure over a 24-hour period for providing healthcare professionals with valuable insights into patient blood pressure fluctuations. The growing emphasis on preventive healthcare and early disease detection is also driving the product adoption.

Growing technological advancements in ambulatory blood pressure monitoring devices have made way for the development of compact and wearable devices with enhanced accuracy and comfort. Rising healthcare expenditure, coupled with initiatives by governments and healthcare organizations to promote the use of remote patient monitoring devices will define the market growth.

The ambulatory blood pressure monitoring devices industry is classified based on device type, operation, configuration, and region.

The market size from the accessories device type segment will generate notable revenue at 8.2% CAGR during the forecast period. The increasing adoption of ambulatory blood pressure monitoring devices for long-term monitoring of hypertension is necessitating the need for compatible accessories to ensure accurate and reliable measurements. Accessories, such as cuffs, adapters, and software solutions also help in enhancing the functionality and product usability, thereby driving the product demand.

Ambulatory blood pressure monitoring devices market from the manual operation segment is anticipated to witness 7.9% CAGR between 2024 and 2032. Despite the emergence of automated monitoring devices, manual ambulatory blood pressure monitors continue to be preferred by healthcare professionals for their accuracy and reliability in measuring BP. Manual BP monitors are also more cost-effective than automated alternatives, making them accessible to a wider range of healthcare facilities and patients, especially in resource-constrained settings.

Asia Pacific ambulatory blood pressure monitoring devices market is projected to exhibit 9.4% CAGR during 202-2032, attributed to the rising prevalence of hypertension and cardiovascular diseases. Rapid technological advancements, such as the development of compact and user-friendly ABPM devices, have encouraged their adoption among both healthcare professionals and patients. The increasing healthcare expenditure, growing awareness about the importance of regular blood pressure monitoring, and favorable government initiatives for promoting preventive healthcare measures will also stimulate the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast calculations
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of hypertension and cardiovascular diseases
      • 3.2.1.2 Growing focus on preventive healthcare
      • 3.2.1.3 Technological advancements
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated with blood pressure monitoring devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Pricing analysis, 2023
  • 3.7 Porter's analysis
    • 3.7.1 Supplier power
    • 3.7.2 Buyer power
    • 3.7.3 Threat of new entrants
    • 3.7.4 Threat of substitutes
    • 3.7.5 Industry rivalry
  • 3.8 PESTEL analysis
  • 3.9 Reimbursement scenario
  • 3.10 Future market trends
  • 3.11 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Products
    • 5.2.1 Digital BP monitors
      • 5.2.1.1 Upper arm monitors
      • 5.2.1.2 Wrist monitors
      • 5.2.1.3 Finger monitors
    • 5.2.2 Aneroid BP monitors
    • 5.2.3 Mercury BP monitors
  • 5.3 Accessories

Chapter 6 Market Estimates and Forecast, By Operation, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Automatic
  • 6.3 Semi-automatic
  • 6.4 Manual

Chapter 7 Market Estimates and Forecast, By Configuration, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Portable
  • 7.3 Desk mounted
  • 7.4 Floor standing
  • 7.5 Wall mounted

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 A&D Company, Limited
  • 9.2 American Diagnostic Corporation
  • 9.3 Beurer GmbH
  • 9.4 Contec
  • 9.5 Dr. Morepen
  • 9.6 ForaCare, Inc.
  • 9.7 GE HealthCare Technologies Inc.
  • 9.8 Hill-Rom Holdings, Inc.
  • 9.9 iHealth Labs Inc
  • 9.10 Koninklijke Philips N.V.
  • 9.11 Microlife Corporation
  • 9.12 OMRON Corporation
  • 9.13 Rossmax International Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦